Date	Article
16 Dec 1998	Gene Therapy Advisory Committee Gives Go Ahead for Oxford BioMedica Breast Cancer Trial
14 Dec 1998	Rhone-Poulenc Rorer Gencell and Oxford BioMedica Establish Collaboration on Gene Expression Control Technology
16 Oct 1998	Additional Commercial Opportunities For The Hypoxia Response Element Revealed At Gene Therapy Meeting
24 Sep 1998	Announces Two New Research Collaborations
13 Aug 1998	Announces Interim Results For The Six Months To 30 June 1998
27 Jul 1998	UK's Leading Gene Therapy Company Awarded DTI Grant To Support Clinical Trial In Breast Cancer
29 Jun 1998	Announces Board Changes
28 May 1998	Presents on Lentiviruses at First Meeting of The American Society of Gene Therapy
20 May 1998	New Gene Delivery Technology for Gene Therapy
23 Apr 1998	Oxford BioMedics PLC completes Financing
25 Mar1998	Appoints Andrew Allars As Non-Executive Director
09 Mar 1998	Invited to Advise on New Gene Therapy Protocols by US National Institute of Health
26 Feb 1998	Preliminary Results For The 15 Months Ended 31 December 1997
26 Feb 1998	Announcement Of Placing & Rights Issue
04 Feb 1998	Oxford BioMedica plc launches new website
26 Jan 1998	Oxford BioMedica Announces Interaction with Rhone-Poulenc Rorer
09 Jan 1998	Oxford BioMedica Develops a New Gene Delivery System to Extend the Applications for Gene Therapy

Website by College Hill - Life Sciences